William G Ondo

Summary

Affiliation: Texas Medical Center
Country: USA

Publications

  1. doi request reprint Globus pallidus deep brain stimulation for refractory idiopathic restless legs syndrome
    William G Ondo
    Department of Neurology, University of Texas Health Science Center at Houston, Houston, TX, USA
    Sleep Med 13:1202-4. 2012
  2. doi request reprint Placebo-controlled trial of lubiprostone for constipation associated with Parkinson disease
    W G Ondo
    Department of Neurology, University of Texas Health Science Center, Houston, TX, USA
    Neurology 78:1650-4. 2012
  3. ncbi request reprint Locomotor response to levodopa in fluctuating Parkinson's disease
    Steven T Moore
    Department of Neurology, Mount Sinai School of Medicine, Box 1135, 1 E 100th St, New York, NY 10029, USA
    Exp Brain Res 184:469-78. 2008
  4. ncbi request reprint Basal ganglia neuronal discharge in primary and secondary dystonia
    Manjit K Sanghera
    Department of Neurosurgery, Baylor College of Medicine, Houston, Texas, USA
    Adv Neurol 94:29-36. 2004
  5. ncbi request reprint Locomotion is increased in a11-lesioned mice with iron deprivation: a possible animal model for restless legs syndrome
    Shen Qu
    Departments of Neurology, Baylor College of Medicine, Houston, Texas 77030, USA
    J Neuropathol Exp Neurol 66:383-8. 2007
  6. ncbi request reprint Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson's disease
    William G Ondo
    Department of Neurology, Baylor College of Medicine, Houston, Texas 77030, USA
    Mov Disord 20:958-63. 2005
  7. ncbi request reprint Intravenous flumazenil for Parkinson's disease: a single dose, double blind, placebo controlled, cross-over trial
    William G Ondo
    Department of Neurology, Baylor College of Medicine, Houston, Texas, USA
    Mov Disord 21:1614-7. 2006
  8. doi request reprint The long-term effects of the dopamine agonist pramipexole in a proposed restless legs syndrome animal model
    Feifei Luo
    Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA
    Sleep Med 12:41-6. 2011
  9. doi request reprint Long-term efficacy of rasagiline in early Parkinson's disease
    Mark F Lew
    Department of Neurology, Keck University of Southern California School of Medicine, Los Angeles, California 90033, USA
    Int J Neurosci 120:404-8. 2010
  10. doi request reprint Memantine for non-motor features of Parkinson's disease: a double-blind placebo controlled exploratory pilot trial
    William G Ondo
    Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA
    Parkinsonism Relat Disord 17:156-9. 2011

Collaborators

Detail Information

Publications57

  1. doi request reprint Globus pallidus deep brain stimulation for refractory idiopathic restless legs syndrome
    William G Ondo
    Department of Neurology, University of Texas Health Science Center at Houston, Houston, TX, USA
    Sleep Med 13:1202-4. 2012
    ..We wish to test whether GPi DBS can improve idiopathic RLS...
  2. doi request reprint Placebo-controlled trial of lubiprostone for constipation associated with Parkinson disease
    W G Ondo
    Department of Neurology, University of Texas Health Science Center, Houston, TX, USA
    Neurology 78:1650-4. 2012
    ..To evaluate the efficacy and tolerability of lubiprostone (Amitiza) for constipation in Parkinson disease (PD) in a double-blind, randomized, controlled study...
  3. ncbi request reprint Locomotor response to levodopa in fluctuating Parkinson's disease
    Steven T Moore
    Department of Neurology, Mount Sinai School of Medicine, Box 1135, 1 E 100th St, New York, NY 10029, USA
    Exp Brain Res 184:469-78. 2008
    ..Ambulatory monitoring of gait objectively measures the dynamic locomotor response to levodopa, and this information could be used to improve daily management of motor fluctuations...
  4. ncbi request reprint Basal ganglia neuronal discharge in primary and secondary dystonia
    Manjit K Sanghera
    Department of Neurosurgery, Baylor College of Medicine, Houston, Texas, USA
    Adv Neurol 94:29-36. 2004
  5. ncbi request reprint Locomotion is increased in a11-lesioned mice with iron deprivation: a possible animal model for restless legs syndrome
    Shen Qu
    Departments of Neurology, Baylor College of Medicine, Houston, Texas 77030, USA
    J Neuropathol Exp Neurol 66:383-8. 2007
    ..This model could be consistent with human RLS, attention deficit hyperactivity disorder, or akathisia...
  6. ncbi request reprint Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson's disease
    William G Ondo
    Department of Neurology, Baylor College of Medicine, Houston, Texas 77030, USA
    Mov Disord 20:958-63. 2005
    ..Larger doses of drug and greater sample sizes might be considered in future studies...
  7. ncbi request reprint Intravenous flumazenil for Parkinson's disease: a single dose, double blind, placebo controlled, cross-over trial
    William G Ondo
    Department of Neurology, Baylor College of Medicine, Houston, Texas, USA
    Mov Disord 21:1614-7. 2006
    ..The medication was well tolerated. The most common adverse event on drug was a sense of "light-headedness" or "dizziness." GABA antagonists represent a novel potential treatment class for PD...
  8. doi request reprint The long-term effects of the dopamine agonist pramipexole in a proposed restless legs syndrome animal model
    Feifei Luo
    Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA
    Sleep Med 12:41-6. 2011
    ..To evaluate the clinical and biological effects of chronic pramipexole (PPX) therapy in a proposed animal model of restless legs syndrome (RLS)...
  9. doi request reprint Long-term efficacy of rasagiline in early Parkinson's disease
    Mark F Lew
    Department of Neurology, Keck University of Southern California School of Medicine, Los Angeles, California 90033, USA
    Int J Neurosci 120:404-8. 2010
    ..Rasagiline was well tolerated, with 11.3% of patients (45/398) withdrawing because of an adverse event. Rasagiline therapy for PD was effective, well tolerated, and safe in this long-term trial...
  10. doi request reprint Memantine for non-motor features of Parkinson's disease: a double-blind placebo controlled exploratory pilot trial
    William G Ondo
    Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA
    Parkinsonism Relat Disord 17:156-9. 2011
    ..To perform an exploratory study evaluating memantine for several common non-motor problems in Parkinson's disease...
  11. doi request reprint Apomorphine injections: predictors of initial common adverse events and long term tolerability
    William G Ondo
    Department of Neurology, Baylor College of Medicine, 6550 Fannin, Ste 1801, Houston, TX 77030, USA
    Parkinsonism Relat Disord 18:619-22. 2012
    ..However, their use is limited by actual and perceived adverse events (AE). To our knowledge, no study has evaluated for predictors of these problems...
  12. ncbi request reprint Ambulatory monitoring of freezing of gait in Parkinson's disease
    Steven T Moore
    Department of Neurology, Mount Sinai School of Medicine, Box 1135, 1 E 100th Street, New York, NY 10029, USA
    J Neurosci Methods 167:340-8. 2008
    ..Individual calibration of the freeze threshold improved accuracy and sensitivity of the device to 89% for detection of FOG with 10% false positives. Ambulatory monitoring may significantly improve clinical management of FOG...
  13. doi request reprint A pilot study: Microlesion effects and tremor outcome in the ventrointermediate deep brain stimulation (VIM-DBS)
    Oraporn Sitburana
    Parkinson s Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX, USA
    Clin Neurol Neurosurg 112:106-9. 2010
    ..To perform a pilot study to investigate the relationship between the microlesion effect (MLE) seen in deep brain stimulation (DBS) of the ventralis intermedius nucleus (VIM) and subsequent tremor response and DBS parameter settings...
  14. doi request reprint Task-specific writing tremor: clinical phenotypes, progression, treatment outcomes, and proposed nomenclature
    William G Ondo
    Department of Neurology, University of Texas Health Science Center, Houston, TX 77030, USA
    Int J Neurosci 122:88-91. 2012
    ..This supports segregation between task-specific tremor and essential tremor but does not support the specific diagnosis of "writing tremor" because many patients progress to tremor with other tasks...
  15. doi request reprint Does the endogenous opiate system play a role in the Restless Legs Syndrome? A pilot post-mortem study
    Arthur S Walters
    Department of Neurology, Vanderbilt University Medical Center, Nashville, TN 37232 2551, USA
    J Neurol Sci 279:62-5. 2009
    ..In addition, other opioid rich areas need to be explored as well as areas implicated in the pathogenesis of RLS such as the red nucleus and raphe nucleus...
  16. ncbi request reprint Selegiline orally disintegrating tablets in patients with Parkinson disease and "wearing off" symptoms
    William G Ondo
    Baylor College of Medicine, Department of Neurology, 6550 Fannin, Houston, TX 77030, USA
    Clin Neuropharmacol 30:295-300. 2007
    ..Most patients on long-term LD therapy eventually experience deterioration at the end of the LD dosing interval, with predictable "wearing off" and "on-off" fluctuations...
  17. pmc Effect of tetrabenazine on computerized dynamic posturography in Huntington disease patients
    Robert Fekete
    Department of Neurology, New York Medical College, Fourth Floor, Munger Pavilion, 40 Sunshine Cottage Road, Valhalla, NY 10595, USA
    Parkinsonism Relat Disord 18:896-8. 2012
    ..Tetrabenazine is approved to treat chorea in Huntington disease, but its effect on posturography scores, and balance in general, is unknown...
  18. doi request reprint Rotigotine improves restless legs syndrome: a 6-month randomized, double-blind, placebo-controlled trial in the United States
    Wayne A Hening
    Department of Neurology, UMDNJ Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA
    Mov Disord 25:1675-83. 2010
    ..Rotigotine transdermal patches releasing 2 to 3 mg/24 hr significantly reduced the severity of RLS symptoms. Treatment efficacy was maintained throughout the 6-month double-blind period...
  19. ncbi request reprint Subthalamic deep brain stimulation in patients with a previous pallidotomy
    William G Ondo
    Department of Neurology, Baylor College of Medicine, Houston, Texas, USA
    Mov Disord 21:1252-4. 2006
    ..This may be partially due to a selection bias, but it may also indicate that prior pallidotomy is a negative predictor of outcome of STN DBS and should be considered in patient selection...
  20. doi request reprint Comparison of orally dissolving carbidopa/levodopa (Parcopa) to conventional oral carbidopa/levodopa: A single-dose, double-blind, double-dummy, placebo-controlled, crossover trial
    William G Ondo
    Department of Neurology, Baylor College of Medicine, Houston, Texas, USA
    Mov Disord 25:2724-7. 2010
    ..However, all trends did favor OD C/L. Adverse events were similar. This small pilot study did not show significant group differences favoring OD C/L; however, larger studies may be justified, and individual patients may benefit...
  21. ncbi request reprint Zonisamide for essential tremor
    William G Ondo
    Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA
    Clin Neuropharmacol 30:345-9. 2007
    ..The pharmacological therapy for essential tremor (ET) is inadequate, and many patients resort to surgical procedures. Zonisamide is an antiepileptic with several potential mechanisms of action...
  22. doi request reprint Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study
    William G Ondo
    Department of Neurology, Baylor College of Medicine, 6550 Fannin, Ste 1801, Houston, TX 77030, USA
    Arch Neurol 65:1337-40. 2008
    ..Many patients with Parkinson disease (PD) have excessive daytime sleepiness and numerous nocturnal sleep abnormalities...
  23. ncbi request reprint Evaluating factors that can influence spirography ratings in patients with essential tremor
    William G Ondo
    Department of Neurology, Baylor College of Medicine, 6550 Fannin Dr, Suite 1801, Houston, TX 77030, USA
    Parkinsonism Relat Disord 11:45-8. 2005
    ..Effort' had little effect on ratings. Based on our results, we recommend that assessment of ET include unsupported, freehand spirals...
  24. ncbi request reprint An open-label pilot study of levetiracetam for essential tremor
    William G Ondo
    Baylor College of Medicine, Department of Neurology, Houston, Texas 77030, USA
    Clin Neuropharmacol 27:274-7. 2004
    ..Adverse events included dizziness (n=2), sedation (n=1), and nervousness (n=1). Levetiracetam was well tolerated but failed to improve tremor consistently in this small trial...
  25. doi request reprint Weight change in Parkinson and Alzheimer patients taking atypical antipsychotic drugs
    Oraporn Sitburana
    Parkinson s Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas, USA
    J Neurol Sci 272:77-82. 2008
    ..The BMI for 28 AD subjects on AA increased 0.01 kg/m(2)/month (95% CI 0.26-0.83, P<0.0001), comparing PD on AA vs. AD on AA. The weight loss seen in the PD/AA group, compared to AD, suggest uniquely altered weight homeostasis in PD...
  26. ncbi request reprint The North American survey of placement and adjustment strategies for deep brain stimulation
    William G Ondo
    Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA
    Stereotact Funct Neurosurg 83:142-7. 2005
    ..Deep brain stimulation (DBS) is gaining wide acceptance as treatment for Parkinson's disease (PD), essential tremor, and dystonia...
  27. doi request reprint Restless legs syndrome
    William G Ondo
    Department of Neurology, Baylor College of Medicine, Houston, TX, USA
    Neurol Clin 27:779-99, vii. 2009
    ..Dopamine agonists are clearly the best investigated and probably the most effective treatments for RLS...
  28. doi request reprint Motor complications in Parkinson's disease
    William G Ondo
    Department of Neurology, University of Texas Health Science Center, Houston, Texas 77030, USA
    Int J Neurosci 121:37-44. 2011
    ..Surgical interventions such as lesioning and deep brain stimulation are considered when pharmacological strategies for motor complications are not satisfactory...
  29. doi request reprint Gabapentin enacarbil in restless legs syndrome: a phase 2b, 2-week, randomized, double-blind, placebo-controlled trial
    Arthur S Walters
    Department of Neurology, Vanderbilt University Medical Center, 1161 21st Ave, Nashville, TN 37232 2551, USA
    Clin Neuropharmacol 32:311-20. 2009
    ..Assess the efficacy and tolerability of gabapentin enacarbil (GEn), a transported prodrug of gabapentin with improved gabapentin exposure, in adults with moderate-to-severe primary restless legs syndrome...
  30. doi request reprint Open-label study assessment of safety and adverse effects of subcutaneous apomorphine injections in treating "off" episodes in advanced Parkinson disease
    Peter A LeWitt
    Department of Neurology, Wayne State University School of Medicine and Henry Ford Hospital, Detroit, MI 48034, USA
    Clin Neuropharmacol 32:89-93. 2009
    ..To assess the safety and adverse effect profile of continued use of intermittent subcutaneous apomorphine to treat "off" episodes in subjects with advanced Parkinson disease...
  31. ncbi request reprint Long-term monitoring of gait in Parkinson's disease
    Steven T Moore
    Department of Neurology, Mount Sinai School of Medicine, New York, NY 10029, USA
    Gait Posture 26:200-7. 2007
    ....
  32. ncbi request reprint Association between restless legs syndrome and essential tremor
    William G Ondo
    Baylor College of Medicine, Houston, Texas, USA
    Mov Disord 21:515-8. 2006
    ....
  33. ncbi request reprint Long-term evaluation of deep brain stimulation of the thalamus
    Rajesh Pahwa
    Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas 66160, USA
    J Neurosurg 104:506-12. 2006
    ..The aim of this study was to evaluate the long-term safety and efficacy of DBS of the ventralis intermedius nucleus (VIM) of the thalamus for PD and ET...
  34. ncbi request reprint A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease
    William G Ondo
    Department of Neurology, Baylor College of Medicine, 6550 Fannin, Suite 1801, Houston, TX 77030, USA
    Neurology 62:37-40. 2004
    ..Based on the relatively high rates of dry mouth seen with botulinum toxin B, there is reason to suspect that it may also improve sialorrhea...
  35. ncbi request reprint Spinal cord dopamine receptor expression and function in mice with 6-OHDA lesion of the A11 nucleus and dietary iron deprivation
    Hongru Zhao
    Department of Neurology, Baylor College of Medicine, Houston, Texas 77030, USA
    J Neurosci Res 85:1065-76. 2007
    ....
  36. ncbi request reprint Predictors of impulsivity and reward seeking behavior with dopamine agonists
    William G Ondo
    Baylor College of Medicine, 6550 Fannin, Ste 1801, Houston, TX 77030, USA
    Parkinsonism Relat Disord 14:28-32. 2008
    ..01), larger doses of DA (p<0.001), and PD, as opposed to RLS (p<0.01), but this lost significance after correcting for dose (p=0.09). Increased impulsivity is common but usually not deleterious...
  37. ncbi request reprint Basal ganglia neuronal discharge in primary and secondary dystonia in patients undergoing pallidotomy
    Manjit K Sanghera
    Department of Neurosurgery, Baylor College of Medicine, 6560 Fannin Street, Houston, TX 77030, USA
    Neurosurgery 52:1358-70; discussion 1370-3. 2003
    ..Basal ganglia neuronal activity in patients undergoing posteroventral pallidotomy (PVP) for the treatment of primary genetic, secondary, or idiopathic dystonia (DYS) was studied to gain a better understanding of the pathophysiology of DYS...
  38. doi request reprint Tetrabenazine treatment for stereotypies and tics associated with dementia
    William G Ondo
    Baylor College of Medicine, Houston, TX, USA
    J Neuropsychiatry Clin Neurosci 24:208-14. 2012
    ..Efficacy has not waned over time. Tetrabenazine dramatically improved stereotypies in patients with dementia. This observation could increase understanding of this interesting phenotype...
  39. ncbi request reprint Olanzapine treatment for dopaminergic-induced hallucinations
    William G Ondo
    Department of Neurology, Baylor College of Medicine, Houston, Texas, USA
    Mov Disord 17:1031-5. 2002
    ..8%) of all patients exposed to drug (including those originally randomly assigned to placebo) remained on olanzapine. In patients with PD, low-dose olanzapine did not significantly improve hallucinations but did worsen motor function...
  40. ncbi request reprint Computerized posturography balance assessment of patients with bilateral ventralis intermedius nuclei deep brain stimulation
    William G Ondo
    Department of Neurology, Baylor College of Medicine, Houston, Texas, USA
    Mov Disord 21:2243-7. 2006
    ..Falls lessened with activation in ET patients. Motor control testing was not changed. Bilateral Vim DBS activation mostly improved balance, but may modestly worsen other specific features...
  41. doi request reprint Comparison of weight gain in treatments for Tourette syndrome: tetrabenazine versus neuroleptic drugs
    William G Ondo
    Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA
    J Child Neurol 23:435-7. 2008
    ..006). Most patients who switched from a neuroleptic drug to tetrabenazine subsequently lost weight. Although the study was not designed to compare efficacy, this tended to be greater with tetrabenazine than with neuroleptic drugs...
  42. ncbi request reprint Heterogeneous phenotype in a family with compound heterozygous parkin gene mutations
    Hao Deng
    Department of Neurology, Baylor College of Medicine, Houston, Tex 77030, USA
    Arch Neurol 63:273-7. 2006
    ..Mutations in the parkin gene (PRKN) cause autosomal recessive early-onset Parkinson disease (EOPD)...
  43. doi request reprint Tolerability and efficacy of switching from oral selegiline to Zydis selegiline in patients with Parkinson's disease
    William G Ondo
    Dept of Neurology, Baylor College of Medicine, 6550 Fannin, Ste 1801, Houston, TX 77030, USA
    Parkinsonism Relat Disord 17:117-8. 2011
    ..Adverse events were mild. Patients generally preferred the Zydis selegiline preparation but the modest difference is of unclear clinical significance given the open label nature of the trial...
  44. ncbi request reprint Exploring the relationship between Parkinson disease and restless legs syndrome
    William G Ondo
    Department of Neurology, Baylor College of Medicine, 6550 Fannin, Suite 1801, Houston, TX 77030
    Arch Neurol 59:421-4. 2002
    ..Restless legs syndrome (RLS) and Parkinson disease (PD) are common neurological conditions that respond to dopaminergic therapy. To our knowledge, the relationship between the two has not been thoroughly explored...
  45. ncbi request reprint Restless legs syndrome
    William G Ondo
    Department of Neurology, Baylor College of Medicine, 6501 Fannin Street, Houston, TX 77030, USA
    Curr Neurol Neurosci Rep 5:266-74. 2005
    ..Genetic studies will hopefully soon identify specific abnormalities. Treatment of restless legs syndrome with dopaminergic medications is highly effective, although augmentation may occur eventually and require dosing flexibility...
  46. ncbi request reprint Restless legs syndrome: pathophysiology, diagnosis and treatment
    Pankaj Satija
    Department of Neurology, Baylor College of Medicine, Houston, Texas 77030, USA
    CNS Drugs 22:497-518. 2008
    ..Other treatment options include gabapentin, or similar antiepileptic drugs, and opioids. High-dose intravenous iron is a promising but still experimental approach...
  47. ncbi request reprint Predictors of battery life for the Activa Soletra 7426 Neurostimulator
    William G Ondo
    Baylor College of Medicine, Department of Neurology, Houston, USA
    Parkinsonism Relat Disord 13:240-2. 2007
    ..002), pulse width (p=0.026), and not using exclusive bipolar settings (p=0.029). The implant location, underlying disease, and sex did not affect battery life. Battery life varied but was generally consistent with published predictors...
  48. ncbi request reprint Withdrawal of visual feedback improves micrographia in Parkinson's disease
    William G Ondo
    Department of Neurology, Baylor College of Medicine, Houston, Texas 77030 2744, USA
    Mov Disord 22:2130-1. 2007
    ..Furthermore, some patients have adapted this simple eye closing strategy when writing, especially signatures...
  49. ncbi request reprint Flumazenil, a GABA antagonist, may improve features of Parkinson's disease
    William G Ondo
    Department of Neurology, Baylor College of Medicine, Houston, Texas 77030, USA
    Mov Disord 18:683-5. 2003
    ..05). Total motor Unified Parkinson's Disease Rating Scale scores modestly improved (P < 0.05). There were no adverse events. Mechanisms by which flumazenil could improve PD are discussed...
  50. ncbi request reprint Olfaction testing in patients with tremor-dominant Parkinson's disease: is this a distinct condition?
    William G Ondo
    Department of Neurology, Baylor College of Medicine, Houston, Texas 77030, USA
    Mov Disord 20:471-5. 2005
    ..It additionally suggests phenotypic overlap between PD and ET...
  51. ncbi request reprint Tetrabenazine for hyperglycemic-induced hemichorea-hemiballismus
    Oraporn Sitburana
    Parkinson s Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas, USA
    Mov Disord 21:2023-5. 2006
    ..Subsequent dose reductions lead to a reemergence of symptoms. Tetrabenazine improves a variety of hyperkinetic movement disorders but, to our knowledge, its use has never been reported for HIHH...
  52. doi request reprint Pharmacological management of essential tremor
    Reza Sadeghi
    Department of Neurology, Baylor College of Medicine, Houston, Texas 77030, USA
    Drugs 70:2215-28. 2010
    ..Several new agents including 1-octanol, pregabalin and sodium oxybate are currently under investigation...
  53. doi request reprint Stereotypies as a manifestation of acute hyperglycemia without ketosis
    José Fidel Baizabal-Carvallo
    Parkinson s Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA
    J Neurol Sci 315:176-7. 2012
    ..A video-case of hyperkinetic movement disorder resembling stereotypies in the context of uncompensated hyperglycemia without ketosis is presented, expanding the clinical phenotype of this disorder...
  54. doi request reprint Hyperglycemic nonketotic states and other metabolic imbalances
    William G Ondo
    Baylor College of Medicine, Houston, TX 77030, USA
    Handb Clin Neurol 100:287-91. 2011
    ..Tetrabenazine has worked well when symptomatic treatment is required. Other rare causes of metabolic choreas include hypoparathyroid abnormalities, hypoglycemia, and hypernatremia...
  55. ncbi request reprint Tetrabenazine treatment for Huntington's disease-associated chorea
    William G Ondo
    Department of Neurology, Baylor College of Medicine, Houston, Texas 77030, USA
    Clin Neuropharmacol 25:300-2. 2002
    ..TBZ was well tolerated and resulted in a significant improvement in modified AIMS scores in HD patients. These results support the use of TBZ for chorea in patients with HD...
  56. ncbi request reprint Restless legs syndrome
    William G Ondo
    Baylor College of Medicine, Houston, TX, USA
    Neurol Clin 23:1165-85, viii. 2005
    ..Effective treatments include dopaminergics and narcotics. Recent advances in our understanding of RLS clinical presentation, epidemiology, etiology, and treatment will be discussed...
  57. ncbi request reprint A pilot study of botulinum toxin A for headache in cervical dystonia
    William G Ondo
    Department of Neurology, Baylor College of Medicine, Houston, TX, USA
    Headache 45:1073-7. 2005
    ..To evaluate the prevalence of associated headache (HA) pain with craniocervical dystonia and the therapeutic effect of BoNT-A injections on the HA component when injected for cervical dystonia...